Literature DB >> 11154438

Porphyromonas gingivalis platelet aggregation activity: outer membrane vesicles are potent activators of murine platelets.

A Sharma1, E K Novak, H T Sojar, R T Swank, H K Kuramitsu, R J Genco.   

Abstract

Recent evidence has established an association between chronic periodontitis and cardiovascular disease. Periodontitis is a chronic inflammatory disease caused by a small group of gram-negative bacteria, of which Porphyromonas gingivalis is considered an important causative agent. It has been proposed that dental plaque bacteria and their products can disseminate into the bloodstream from the site of infection and promote thromboembolic events associated with atherosclerosis and myocardial infarction. In this regard, Streptococcus sanguis and P. gingivalis have been shown to induce platelet aggregation in vitro. Here we report that P. gingivalis was able to induce platelet aggregation, and that oral strains of Actinobaillus actinomycetemcomitans, Bacteroides forsythus, Campylobacter rectus, Fusobacterium nucleatum, Prevotella intermedia and Trepenoma denticola failed to aggregate platelets when tested for platelet aggregation activity under similar conditions. Additionally, we show that vesicles (outer membrane evaginations that are shed into the environment by the bacteria) of P. gingivalis are potent inducers of mouse platelet aggregation in vitro. In summary, our data show that i) initial adherence of the bacterium to platelet may be facilitated by P. gingivalis fimbriae and ii) P. gingivalis vesicles possess platelet aggregation-inducing activity.

Entities:  

Mesh:

Year:  2000        PMID: 11154438     DOI: 10.1034/j.1399-302x.2000.150610.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  29 in total

Review 1.  Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life.

Authors:  Brooke L Deatherage; Brad T Cookson
Journal:  Infect Immun       Date:  2012-03-12       Impact factor: 3.441

Review 2.  Bacterial outer membrane vesicles in disease and preventive medicine.

Authors:  Can M Unal; Viveka Schaar; Kristian Riesbeck
Journal:  Semin Immunopathol       Date:  2010-12-12       Impact factor: 9.623

Review 3.  Outer membrane vesicles for vaccination and targeted drug delivery.

Authors:  Sihan Wang; Jin Gao; Zhenjia Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-04-26

Review 4.  Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis.

Authors:  Linda L Humphrey; Rongwei Fu; David I Buckley; Michele Freeman; Mark Helfand
Journal:  J Gen Intern Med       Date:  2008-09-20       Impact factor: 5.128

Review 5.  Immune modulation by bacterial outer membrane vesicles.

Authors:  Maria Kaparakis-Liaskos; Richard L Ferrero
Journal:  Nat Rev Immunol       Date:  2015-05-15       Impact factor: 53.106

Review 6.  High molecular weight bioemulsifiers, main properties and potential environmental and biomedical applications.

Authors:  Inès Mnif; Dhouha Ghribi
Journal:  World J Microbiol Biotechnol       Date:  2015-03-05       Impact factor: 3.312

Review 7.  Versatile effects of bacterium-released membrane vesicles on mammalian cells and infectious/inflammatory diseases.

Authors:  You-Jiang Yu; Xiao-Hong Wang; Guo-Chang Fan
Journal:  Acta Pharmacol Sin       Date:  2017-08-31       Impact factor: 6.150

Review 8.  The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes.

Authors:  Lea M Beaulieu; Jane E Freedman
Journal:  Thromb Res       Date:  2009-11-27       Impact factor: 3.944

9.  Inflammation as a potential mediator for the association between periodontal disease and Alzheimer's disease.

Authors:  Amber Watts; Eileen M Crimmins; Margaret Gatz
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

Review 10.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.